Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.

Carpenter MA, Hoberman A, Mattoo TK, Mathews R, Keren R, Chesney RW, Moxey-Mims M, Greenfield SP; RIVUR Trial Investigators.

Pediatrics. 2013 Jul;132(1):e34-45. doi: 10.1542/peds.2012-2301. Epub 2013 Jun 10.

2.

Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.

Mattoo TK, Chesney RW, Greenfield SP, Hoberman A, Keren R, Mathews R, Gravens-Mueller L, Ivanova A, Carpenter MA, Moxey-Mims M, Majd M, Ziessman HA; RIVUR Trial Investigators.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):54-61. doi: 10.2215/CJN.05210515. Epub 2015 Nov 10.

3.

Antimicrobial prophylaxis for children with vesicoureteral reflux.

RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, Keren R, Mathews R, Pohl HG, Kropp BP, Skoog SJ, Nelson CP, Moxey-Mims M, Chesney RW, Carpenter MA.

N Engl J Med. 2014 Jun 19;370(25):2367-76. doi: 10.1056/NEJMoa1401811. Epub 2014 May 4.

4.

Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study.

Keren R, Carpenter MA, Hoberman A, Shaikh N, Matoo TK, Chesney RW, Matthews R, Gerson AC, Greenfield SP, Fivush B, McLurie GA, Rushton HG, Canning D, Nelson CP, Greenbaum L, Bukowski T, Primack W, Sutherland R, Hosking J, Stewart D, Elder J, Moxey-Mims M, Nyberg L.

Pediatrics. 2008 Dec;122 Suppl 5:S240-50. doi: 10.1542/peds.2008-1285d.

5.

The RIVUR trial: a factual interpretation of our data.

Mattoo TK, Carpenter MA, Moxey-Mims M, Chesney RW; RIVUR Trial Investigators.

Pediatr Nephrol. 2015 May;30(5):707-12. doi: 10.1007/s00467-014-3022-1. Epub 2015 Jan 6.

6.

Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.

Keren R, Shaikh N, Pohl H, Gravens-Mueller L, Ivanova A, Zaoutis L, Patel M, deBerardinis R, Parker A, Bhatnagar S, Haralam MA, Pope M, Kearney D, Sprague B, Barrera R, Viteri B, Egigueron M, Shah N, Hoberman A.

Pediatrics. 2015 Jul;136(1):e13-21. doi: 10.1542/peds.2015-0409. Epub 2015 Jun 8.

7.

The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes.

Mathews R, Mattoo TK.

Adv Chronic Kidney Dis. 2015 Jul;22(4):325-30. doi: 10.1053/j.ackd.2015.04.002. Review.

PMID:
26088078
8.

Positioning irrigation of contrast cystography for diagnosis of occult vesicoureteric reflux: association with technetium-99m dimercaptosuccinic acid scans.

Berger C, Becker T, Koen M, Zeino M, Fitz F, Beheshti M, Wolf-Kohlmeier I, Haim S, Riccabona M.

J Pediatr Urol. 2013 Dec;9(6 Pt A):846-50. doi: 10.1016/j.jpurol.2012.11.010. Epub 2012 Dec 5.

PMID:
23219319
9.

Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double-blind placebo-controlled trial.

Hari P, Hari S, Sinha A, Kumar R, Kapil A, Pandey RM, Bagga A.

Pediatr Nephrol. 2015 Mar;30(3):479-86. doi: 10.1007/s00467-014-2943-z. Epub 2014 Aug 31.

PMID:
25173357
10.

Impact of micturating cystourethrography and DMSA renal scintigraphy on the investigation scheme in children with urinary tract infection.

Ajdinović B, Jauković L, Krstić Z, Dopuda M.

Ann Nucl Med. 2008 Oct;22(8):661-5. doi: 10.1007/s12149-008-0178-4. Epub 2008 Nov 4.

PMID:
18982468
11.

Hidden high-grade vesicoureteral reflux is the main risk factor for chronic renal damage in children under the age of two years with first urinary tract infection.

Zaffanello M, Cataldi L, Brugnara M, Franchini M, Bruno C, Fanos V.

Scand J Urol Nephrol. 2009;43(6):494-500. doi: 10.3109/00365590903286663.

PMID:
19968584
12.

Sonographic assessment of the effect of vesicoureteral reflux and urinary tract infections on growth of the pediatric solitary kidney.

Ross I, Ahn HJ, Roelof B, Barber T, Huynh V, Rockette A, Popovic M, Chen JJ, Steinhardt G.

J Pediatr Urol. 2015 Jun;11(3):145.e1-6. doi: 10.1016/j.jpurol.2015.02.012. Epub 2015 Mar 13.

13.

Acute 99mTc DMSA scan predicts dilating vesicoureteral reflux in young children with a first febrile urinary tract infection: a population-based cohort study.

Sheu JN, Wu KH, Chen SM, Tsai JD, Chao YH, Lue KH.

Clin Nucl Med. 2013 Mar;38(3):163-8. doi: 10.1097/RLU.0b013e318279f112.

PMID:
23354031
14.

Dimercaptosuccinic acid scan or ultrasound in screening for vesicoureteral reflux among children with urinary tract infections.

Shaikh N, Spingarn RB, Hum SW.

Cochrane Database Syst Rev. 2016 Jul 5;7:CD010657. doi: 10.1002/14651858.CD010657.pub2. Review.

PMID:
27378557
15.

Role of procalcitonin in predicting dilating vesicoureteral reflux in young children hospitalized with a first febrile urinary tract infection.

Sun HL, Wu KH, Chen SM, Chao YH, Ku MS, Hung TW, Liao PF, Lue KH, Sheu JN.

Pediatr Infect Dis J. 2013 Sep;32(9):e348-54. doi: 10.1097/INF.0b013e3182905d83.

PMID:
23584577
16.

DMSA study performed during febrile urinary tract infection: a predictor of patient outcome?

Camacho V, Estorch M, Fraga G, Mena E, Fuertes J, Hernández MA, Flotats A, Carrió I.

Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):862-6. Epub 2004 Feb 3.

PMID:
14758509
17.

Technetium-99m-dimercaptosuccinic acid renal scintigraphy in children with urinary tract infections.

Ajdinović B, Jauković L, Krstić Z, Dopuda M.

Hell J Nucl Med. 2006 Jan-Apr;9(1):27-30.

PMID:
16617390
18.

Screening high-grade vesicoureteral reflux in young infants with a febrile urinary tract infection.

Tsai JD, Huang CT, Lin PY, Chang JH, Lee MD, Huang FY, Shih BF, Hung HY, Hsu CH, Kao HA, Lin CC.

Pediatr Nephrol. 2012 Jun;27(6):955-63. doi: 10.1007/s00467-012-2104-1. Epub 2012 Mar 1.

PMID:
22374404
19.
20.

Relationship among vesicoureteral reflux, urinary tract infection and renal damage in children.

Swerkersson S, Jodal U, Sixt R, Stokland E, Hansson S.

J Urol. 2007 Aug;178(2):647-51; discussion 650-1. Epub 2007 Jun 15.

PMID:
17574623

Supplemental Content

Support Center